This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Caine DB, Langston JW, Martin WRW (1985) Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease. Nature 317:246–248
Davis GC, Williams AC, Markey SP (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiat Res 1:249–254
Kalant H (2001) The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. Can Med Assoc J 165:917–928
Langston JW, Ballard P, Tetrud JW, Irwin L (1983) Chronic Parkinsonism in humans due to a product of meperidine-analogue synthesis. Science 219:979–980
Langston JW, Ballard P (1984) Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and pathogenesis of Parkinson's disease. Can J Neurol Sci 11:160–165
McCann UD, Slate SO, Ricaurte GA (1996) Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"). Drug Safety 15:107–115
Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition; before, during, and after a Saturday night dance. Psychopharmacology 139:261–268
Parrott AC, Buchanan T, Scholey AB, Heffernan TM, Ling J, Rodgers J (2002) Ecstasy/MDMA attributed problems reported by novice, moderate and heavy users. Hum Psychopharmacol 17:309–312
Peroutka SJ, Newman H, Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273–277
Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("Ecstasy"). Science 297:2260–2263
Rodgers J (2000) Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology 151:19–24
Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J (2003) Increased intensity of ecstasy and polydrug use in the more experienced ecstasy users. Addict Behav (in press)
Snyder SH (1984) Clues to aetiology from a toxin. Nature 311:514
About this article
Cite this article
Parrott, A.C., Buchanan, T., Heffernan, T.M. et al. Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167, 449–450 (2003). https://doi.org/10.1007/s00213-003-1447-5
- Heavy User
- Ecstasy User